Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 92.28 USD -0.38% Market Closed
Market Cap: 114.9B USD
Have any thoughts about
Gilead Sciences Inc?
Write Note

Gilead Sciences Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gilead Sciences Inc
Operating Expenses Peer Comparison

Comparables:
ABBV
AMGN
ALNY
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$11.2B
CAGR 3-Years
-3%
CAGR 5-Years
4%
CAGR 10-Years
-8%
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$21.9B
CAGR 3-Years
-4%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$13.4B
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-4%
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Operating Expenses
-$2B
CAGR 3-Years
-14%
CAGR 5-Years
-14%
CAGR 10-Years
-17%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.9B
CAGR 3-Years
-10%
CAGR 5-Years
-16%
CAGR 10-Years
-15%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.8B
CAGR 3-Years
-23%
CAGR 5-Years
-16%
CAGR 10-Years
-17%

See Also

What is Gilead Sciences Inc's Operating Expenses?
Operating Expenses
-11.2B USD

Based on the financial report for Sep 30, 2024, Gilead Sciences Inc's Operating Expenses amounts to -11.2B USD.

What is Gilead Sciences Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-8%

Over the last year, the Operating Expenses growth was 2%. The average annual Operating Expenses growth rates for Gilead Sciences Inc have been -3% over the past three years , 4% over the past five years , and -8% over the past ten years .

Back to Top